KellyOCG Earns Recognition as a John Deere “Partner-level Supplier”
April 23, 2024 07:30 ET
|
Kelly Services, Inc.
KellyOCG has earned recognition as a Partner-level supplier for 2023 in the John Deere Achieving Excellence Program.
Lisata Therapeutics and Qilu Pharmaceutical Announce First Patient Treated in Qilu’s Phase 2 Trial in China of LSTA1 in Patients with Metastatic Pancreatic Ductal Adenocarcinoma
April 23, 2024 07:30 ET
|
Lisata Therapeutics, Inc.
BASKING RIDGE, N.J. and JINAN, China, April 23, 2024 (GLOBE NEWSWIRE) -- Lisata Therapeutics, Inc. (Nasdaq: LSTA) (“Lisata” or the “Company”), a clinical-stage pharmaceutical company developing...
Kiniksa Pharmaceuticals Reports First Quarter 2024 Financial Results and Recent Portfolio Execution
April 23, 2024 07:30 ET
|
Kiniksa Pharmaceuticals, Ltd.
– ARCALYST® (rilonacept) Q1 2024 net product revenue of $78.9 million, representing 85% year-over-year growth –– ARCALYST 2024 expected net product revenue increased to $370 - $390 million ––...
Dime Community Bancshares, Inc. Reports First Quarter 2024 Results With Earnings Per Share Increasing By 11% Versus the Prior Quarter
April 23, 2024 07:15 ET
|
Dime Community Bancshares, Inc.
Dime Community Bancshares, Inc. Reports First Quarter 2024 Results
CorVel Announces New Integrations for Managed Care Services Enabling Partners to Increase Connectivity and Create a Seamless Workflow Experience
April 23, 2024 07:08 ET
|
CorVel Corp.
CorVel (NASDAQ: CRVL) unveils AI-driven managed care solutions, offering seamless integration and enhanced insights for partners, improving patient care.
Manhattan Bridge Capital, Inc. Reports First Quarter Results for 2024
April 23, 2024 07:05 ET
|
Manhattan Bridge Capital, Inc.
GREAT NECK, N.Y., April 23, 2024 (GLOBE NEWSWIRE) -- Manhattan Bridge Capital, Inc. (Nasdaq: LOAN) announced today that its net income for the three months ended March 31, 2024...
Lantronix to Participate in the 21st Annual Craig-Hallum Institutional Investor Conference on May 29, 2024
April 23, 2024 07:02 ET
|
Lantronix, Inc.
Lantronix to Participate in the 21st Annual Craig-Hallum Institutional Investor Conference on May 29, 2024
Apellis Pharmaceuticals to Host Conference Call on May 7, 2024, to Discuss First Quarter 2024 Financial Results
April 23, 2024 07:00 ET
|
Apellis Pharmaceuticals, Inc.
WALTHAM, Mass., April 23, 2024 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (Nasdaq: APLS) today announced that the company will host a conference call and webcast to discuss its first quarter...
Omega Therapeutics to Present New Preclinical Data on Epigenomic Upregulation at the American Society of Gene and Cell Therapy 27th Annual Meeting
April 23, 2024 07:00 ET
|
Omega Therapeutics
CAMBRIDGE, Mass., April 23, 2024 (GLOBE NEWSWIRE) -- Omega Therapeutics, Inc. (Nasdaq: OMGA) (“Omega”), a clinical-stage biotechnology company pioneering the development of a new class of...
Century Therapeutics to Present at Chardan’s 8th Annual Genetic Medicines and Cell Therapy Manufacturing Summit
April 23, 2024 07:00 ET
|
Century Therapeutics, Inc.
PHILADELPHIA, April 23, 2024 (GLOBE NEWSWIRE) -- Century Therapeutics (NASDAQ: IPSC), an innovative biotechnology company developing induced pluripotent stem cell (iPSC)-derived cell therapies in...